The art and science of cellular health
Reshaping the way we detect and treat complex human disease
The importance of early disease detection and diagnosis
Early diagnosis of complex human disease improves patient outcomes by providing care at the earliest possible stage giving them the best chance for successful treatment. When care is delayed or inaccessible there is a lower quality of treatment, greater problems associated with treatment, and higher cost of care.
The global burden of disease and health risk
people worldwide suffer from chronic obstructive pulmonary disease
people die globally each year from heart disease
women around the world die each due to pregnancy or delivery complications
of the population worldwide is affected by chronic kidney disease
Changing the paradigm of healthcare intervention with early disease detection
Our science and revolutionary bioanalytical platform are reshaping health care intervention by enabling the early noninvasive detection of silently progressing complex disease. With a focus in organ and women’s health, we have broken new ground in advanced detection diagnostics.
Our approach to changing how we predict and detect disease and health difficulties
We have built our approach around novel DNA methylation analysis to identify risk for the development of a specific disease very early, prior to the onset of symptoms. Through advanced analytics and research, we transform this information into signatures to detect disease early when treatment may be more successful.
Here’s how we do it:
- Rapidly sequence whole genomes
- Deeply sequence target regions
- Utilize RNA sequencing to discover novel RNA variants and splice sites
- Quantify mRNAs for gene expression analysis
- Analyze epigenetic factors with genome-wide methylation and protein interactions
- Sequence organ samples to study disease
- Study the human microbiome
- Identify novel pathogens